More on HIND
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $2.19 |
|
|||
| Open | $2.16 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $2.18 | ||||
| Day Low | $2.12 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 10,008 | ||||
- Vyome gets Chinese patent for besifloxacin acne gel
- Vyome Granted Chinese Patent Strengthening Immuno-Inflammation Portfolio
- Form 8-K Vyome Holdings, Inc For: May 28
- Vyome Holdings Reports First Quarter 2026 Results With Key FDA Filings and Strong Balance Sheet
- Form 10-Q Vyome Holdings, Inc For: Mar 31
- Litchfield Hills Starts Vyome Holdings (HIND) at Buy
- Form 8-K Vyome Holdings, Inc For: Apr 24
- Vyome reports positive phase 2 results for cancer wound treatment
- Vyome Presents Transformational VT-1953 Phase 2 Clinical Study Data at Prestigious AACR 2026
- Vyome to present phase 2 data for wound treatment at AACR meeting
Entities mentioned with HIND
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Earnings | View Related Stories »
- PDUFA | View Related Stories »
- Maxim Group | View Related Stories »
- Show More...
